My NCBISign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 120

    1.

    WISP3 and RhoC guanosine triphosphatase cooperate in the development of inflammatory breast cancer.

    Kleer CG, Zhang Y, Pan Q, Gallagher G, Wu M, Wu ZF, Merajver SD.

    Breast Cancer Res. 2004;6(1):R110-5.PMID: 14696649 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    WISP3 and RhoC guanosine triphosphatase cooperate in the development of inflammatory breast cancer.

    Kleer CG, Zhang Y, Pan Q, Gallagher G, Wu M, Wu ZF, Merajver SD.

    Breast Cancer Res. 2004;6(2):R110-5.PMID: 15602803 [PubMed - indexed for MEDLINE]Related articles

    3.

    RhoC GTPase overexpression modulates induction of angiogenic factors in breast cells.

    van Golen KL, Wu ZF, Qiao XT, Bao L, Merajver SD.

    Neoplasia. 2000 Sep-Oct;2(5):418-25.PMID: 11191108 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    RhoC GTPase, a novel transforming oncogene for human mammary epithelial cells that partially recapitulates the inflammatory breast cancer phenotype.

    van Golen KL, Wu ZF, Qiao XT, Bao LW, Merajver SD.

    Cancer Res. 2000 Oct 15;60(20):5832-8.PMID: 11059780 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Reversion of RhoC GTPase-induced inflammatory breast cancer phenotype by treatment with a farnesyl transferase inhibitor.

    van Golen KL, Bao L, DiVito MM, Wu Z, Prendergast GC, Merajver SD.

    Mol Cancer Ther. 2002 Jun;1(8):575-83.PMID: 12479217 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    WISP3 is a novel tumor suppressor gene of inflammatory breast cancer.

    Kleer CG, Zhang Y, Pan Q, van Golen KL, Wu ZF, Livant D, Merajver SD.

    Oncogene. 2002 May 9;21(20):3172-80.PMID: 12082632 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Overexpression of caveolin-1 and -2 in cell lines and in human samples of inflammatory breast cancer.

    Van den Eynden GG, Van Laere SJ, Van der Auwera I, Merajver SD, Van Marck EA, van Dam P, Vermeulen PB, Dirix LY, van Golen KL.

    Breast Cancer Res Treat. 2006 Feb;95(3):219-28. Epub 2005 Oct 22.PMID: 16244790 [PubMed - indexed for MEDLINE]Related articles

    8.

    Molecular determinants of the inflammatory breast cancer phenotype.

    Houchens NW, Merajver SD.

    Oncology (Williston Park). 2008 Dec;22(14):1556-61; discussion 1561, 1565-8, 1576.PMID: 19198217 [PubMed - indexed for MEDLINE]Related articles

    9.

    WISP3 (CCN6) is a secreted tumor-suppressor protein that modulates IGF signaling in inflammatory breast cancer.

    Kleer CG, Zhang Y, Pan Q, Merajver SD.

    Neoplasia. 2004 Mar-Apr;6(2):179-85.PMID: 15140407 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Mitogen activated protein kinase pathway is involved in RhoC GTPase induced motility, invasion and angiogenesis in inflammatory breast cancer.

    van Golen KL, Bao LW, Pan Q, Miller FR, Wu ZF, Merajver SD.

    Clin Exp Metastasis. 2002;19(4):301-11.PMID: 12090470 [PubMed - indexed for MEDLINE]Related articles

    11.

    A novel putative low-affinity insulin-like growth factor-binding protein, LIBC (lost in inflammatory breast cancer), and RhoC GTPase correlate with the inflammatory breast cancer phenotype.

    van Golen KL, Davies S, Wu ZF, Wang Y, Bucana CD, Root H, Chandrasekharappa S, Strawderman M, Ethier SP, Merajver SD.

    Clin Cancer Res. 1999 Sep;5(9):2511-9.PMID: 10499627 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    RhoC induces differential expression of genes involved in invasion and metastasis in MCF10A breast cells.

    Wu M, Wu ZF, Kumar-Sinha C, Chinnaiyan A, Merajver SD.

    Breast Cancer Res Treat. 2004 Mar;84(1):3-12.PMID: 14999149 [PubMed - indexed for MEDLINE]Related articles

    13.

    Expression of WISP3 and RhoC Genes at mRNA and Protein Levels in Inflammatory and Noninflammatory Breast Cancer in Tunisian Patients.

    Marrakchi R, Khadimallah I, Ouerhani S, Gamoudi A, Khomsi F, Bouzaine H, Benamor M, Bougatef K, Mnif S, Zitoun R, Benna F, Boussen H, Rahal K, Elgaaied AB.

    Cancer Invest. 2009 Dec 16. [Epub ahead of print]PMID: 20014943 [PubMed - as supplied by publisher]Related articles

    14.

    Anti-RhoA and anti-RhoC siRNAs inhibit the proliferation and invasiveness of MDA-MB-231 breast cancer cells in vitro and in vivo.

    Pillé JY, Denoyelle C, Varet J, Bertrand JR, Soria J, Opolon P, Lu H, Pritchard LL, Vannier JP, Malvy C, Soria C, Li H.

    Mol Ther. 2005 Feb;11(2):267-74.PMID: 15668138 [PubMed - indexed for MEDLINE]Related articles

    15.

    [Correlation of expression of RhoC with invasiveness of prostate cancer cell line PC-3M in vitro]

    Yuan Z, Su J, You JF, Wang JL, Cui XL, Zheng J.

    Zhonghua Yi Xue Za Zhi. 2008 Jan 1;88(1):51-5. Chinese. PMID: 18346381 [PubMed - indexed for MEDLINE]Related articles

    16.

    Analysis of RhoC expression and lymphovascular emboli in inflammatory vs non-inflammatory breast cancers in Egyptian patients.

    Lo AC, Georgopoulos A, Kleer CG, Banerjee M, Omar S, Khaled H, Eissa S, Hablas A, Omar HG, Douglas JA, Merajver SD, Soliman AS.

    Breast. 2009 Feb;18(1):55-9. Epub 2009 Jan 20.PMID: 19157876 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    RhoC-GTPase is a novel tissue biomarker associated with biologically aggressive carcinomas of the breast.

    Kleer CG, Griffith KA, Sabel MS, Gallagher G, van Golen KL, Wu ZF, Merajver SD.

    Breast Cancer Res Treat. 2005 Sep;93(2):101-10.PMID: 16187229 [PubMed - indexed for MEDLINE]Related articles

    18.

    Inhibition of CCN6 (WISP3) expression promotes neoplastic progression and enhances the effects of insulin-like growth factor-1 on breast epithelial cells.

    Zhang Y, Pan Q, Zhong H, Merajver SD, Kleer CG.

    Breast Cancer Res. 2005;7(6):R1080-9. Epub 2005 Nov 8.PMID: 16457688 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Molecular and pharmacological blockade of the EP4 receptor selectively inhibits both proliferation and invasion of human inflammatory breast cancer cells.

    Robertson FM, Simeone AM, Mazumdar A, Shah AH, McMurray JS, Ghosh S, Cristofanilli M.

    J Exp Ther Oncol. 2008;7(4):299-312.PMID: 19227010 [PubMed - indexed for MEDLINE]Related articles

    20.

    Gene expression profile analysis of an isogenic tumour metastasis model reveals a functional role for oncogene AF1Q in breast cancer metastasis.

    Li DQ, Hou YF, Wu J, Chen Y, Lu JS, Di GH, Ou ZL, Shen ZZ, Ding J, Shao ZM.

    Eur J Cancer. 2006 Dec;42(18):3274-86. Epub 2006 Sep 18.PMID: 16979889 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity

    You are here: NCBI > Literature > PubMed
    Write to the Help Desk